Dissecting the reduction in cardiovascular death with SGLT2 inhibitors: Potential contribution of effects on ventricular arrhythmias and sudden cardiac death?

Type 2 diabetes is associated with a higher risk of cardiac arrhythmias, especially in presence of cardiovascular disease and/or heart failure. Ventricular arrhythmias (VA: tachycardia/fibrillation) may lead to sudden cardiac arrest/death (SCA/SCD). Sodium-glucose cotransporter type 2 inhibitors (SG...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Diabetes Epidemiology and Management
Glavni autor: André J Scheen
Format: Članak
Izdano: Elsevier 2022-10-01
Teme:
Cardiac arrhythmia
Heart failure
SGLT2 inhibitor
Sudden cardiac death
Type 2 diabetes
Ventricular fibrillation
Online pristup:http://www.sciencedirect.com/science/article/pii/S2666970622000579
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Internet

http://www.sciencedirect.com/science/article/pii/S2666970622000579

Similar Items